Cooper Cos (COO) Stock
Global contact lenses and fertility products maker. Here's the price, business snapshot, and what's worth knowing about Cooper Cos in October 2026.
CooperCompanies (ticker: COO) is a global healthcare company best known for two businesses: CooperVision, a leading maker of soft contact lenses, and CooperSurgical, which supplies fertility, gynaecology and surgical products. CooperVision generates recurring revenue through contact lens replacement cycles and a broad product range across daily, monthly and speciality lenses, while CooperSurgical adds exposure to the women’s health and fertility care markets. The business has a meaningful international footprint and benefits from demographic trends, rising vision correction demand and expanding access to fertility services. Key growth drivers include product innovation, expanded distribution (including online channels), and expansion into emerging markets. Investors should weigh these opportunities against risks such as competitive pressures, regulatory approval and reimbursement dynamics, currency headwinds and supply-chain exposure. This summary is for general, educational purposes only and is not personalised investment advice; values can rise and fall and past performance does not predict future results.
Cooper Cos (COO) Stock Forecast
Analyst price target, next 12 months
$91.00
+59.9% vs today's $56.91
Price range over the last 12 months
Close to its 12-month low
Analysts covering Cooper Cos have a consensus 12-month target of $91.00, above the current price of $56.91.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 5 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Cooper Companies' stock, anticipating a future price increase to $91.
Financial Health
Cooper Cos Inc is performing well with strong profits and cash flow, indicating solid financial stability.
Dividend
Cooper Cos Inc's projected dividend yield of 0.1% suggests limited returns for income-focused investors. If you invested $1000, you would be paid $1.30 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Recurring revenue model
Contact lenses create repeat purchases and predictable revenue from replacement cycles, though sales can vary with competition and consumer trends.
Global market exposure
Broad international reach provides growth opportunities as vision care and fertility services expand, while also introducing currency and regional risks.
Product innovation focus
Investment in new lens technologies and fertility solutions can drive share gains, yet regulatory approvals and R&D outcomes are uncertain.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
